BE885527A - Compositions pharmaceutiques pour nutrition parenterale - Google Patents

Compositions pharmaceutiques pour nutrition parenterale

Info

Publication number
BE885527A
BE885527A BE0/202328A BE202328A BE885527A BE 885527 A BE885527 A BE 885527A BE 0/202328 A BE0/202328 A BE 0/202328A BE 202328 A BE202328 A BE 202328A BE 885527 A BE885527 A BE 885527A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
parenteral nutrition
nutrition
parenteral
pharmaceutical
Prior art date
Application number
BE0/202328A
Other languages
English (en)
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of BE885527A publication Critical patent/BE885527A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/202328A 1979-10-05 1980-10-03 Compositions pharmaceutiques pour nutrition parenterale BE885527A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT50467/79A IT1120033B (it) 1979-10-05 1979-10-05 Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale

Publications (1)

Publication Number Publication Date
BE885527A true BE885527A (fr) 1981-02-02

Family

ID=11273028

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/202328A BE885527A (fr) 1979-10-05 1980-10-03 Compositions pharmaceutiques pour nutrition parenterale

Country Status (13)

Country Link
US (1) US4320145A (fr)
JP (1) JPS5661310A (fr)
AT (1) AT395111B (fr)
BE (1) BE885527A (fr)
CA (1) CA1154678A (fr)
CH (1) CH641675A5 (fr)
DE (1) DE3037479A1 (fr)
FR (1) FR2468371A1 (fr)
GB (1) GB2059262B (fr)
IL (1) IL61190A (fr)
IT (1) IT1120033B (fr)
LU (1) LU82818A1 (fr)
NL (1) NL8005450A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
JP2518636B2 (ja) * 1987-02-13 1996-07-24 雪印乳業株式会社 重症感染症及び広範囲熱症治療経腸栄養剤
FR2635264B1 (fr) * 1988-08-12 1992-02-28 Bellon Labor Sa Roger Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
SK288072B6 (sk) 1999-10-11 2013-05-03 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
GB0306394D0 (en) * 2003-03-20 2003-04-23 Univ Nottingham Carnitine retention
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040346A1 (it) * 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US20060105972A1 (en) 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) * 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639532A (fr) *
FR3707M (fr) * 1963-11-05 1965-11-22 Belge Produits Chimiques Sa Association de la carnitine a des émulsions lipidiques.
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
JPS5460236A (en) * 1977-10-21 1979-05-15 Mitsubishi Electric Corp Etching method
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
IT1116037B (it) 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
DE2921852A1 (de) * 1979-05-29 1980-12-11 Fresenius Chem Pharm Ind Lipide senkendes mittel
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion

Also Published As

Publication number Publication date
FR2468371B1 (fr) 1984-05-04
JPS5661310A (en) 1981-05-26
GB2059262A (en) 1981-04-23
JPS643847B2 (fr) 1989-01-23
LU82818A1 (fr) 1981-02-02
IL61190A (en) 1984-06-29
GB2059262B (en) 1983-11-09
AT395111B (de) 1992-09-25
CH641675A5 (it) 1984-03-15
IT7950467A0 (it) 1979-10-05
DE3037479C2 (fr) 1988-09-08
CA1154678A (fr) 1983-10-04
ATA495580A (de) 1985-03-15
DE3037479A1 (de) 1981-05-21
IL61190A0 (en) 1980-11-30
US4320145A (en) 1982-03-16
NL8005450A (nl) 1981-04-07
FR2468371A1 (fr) 1981-05-08
IT1120033B (it) 1986-03-19

Similar Documents

Publication Publication Date Title
BE885527A (fr) Compositions pharmaceutiques pour nutrition parenterale
ZA771091B (en) Pharmaceutical compositions
ZA774920B (en) Pharmaceutical compositions
BE818381A (fr) Composes et formulations pour detergence
PT66622B (en) Pharmaceutical compositions
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
GR61176B (en) Pharmaceutical compositions and process for the preparation thereof
AU3111677A (en) Pharmaceutical compositions
FI803767L (fi) Cortikosteroid innehaollande farmaceutiska blandningar
LU81318A1 (fr) Composition pharmaceutique pour nutrition parenterale
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
MY8600617A (en) Pharmaceutical compositions
NZ186147A (en) Sterolin pharmaceutical compositions
IL59836A0 (en) Pharmaceutical oxytetracycline compositions
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
IL58621A0 (en) Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
FR2527078B1 (fr) Compositions pharmaceutiques anti-ulceres
PT66509B (en) Pharmaceutical compositions
GB1547206A (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
HK3984A (en) Pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
IE42772L (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.

Effective date: 20001003